venBio Global Strategic Fund III, L.P. — Form D/A
venBio Global Strategic Fund III, L.P. of SAN FRANCISCO, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2019-03-26. The offering totals $350.0M, of which $118.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2019-03-26
- Form: D/A
- Accession: 0001739920-19-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $350.0M
- Amount sold: $118.0M
- Remaining: $232.0M
- Minimum investment: $5.0M
- Investors: 8
- Date of first sale: 2018-06-14
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-314554
Issuer
- Name: venBio Global Strategic Fund III, L.P.
- CIK: 0001739920
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2018
- Address: 1700 OWENS STREET, SAN FRANCISCO, CA, 94158
- Phone: 415-522-0100
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Corey Goodman | Director | Cambridge, MA |
| Aaron Royston | Executive Officer | Cambridge, MA |
| David Pezeshki | Executive Officer | San Francisco, CA |
| Robert Adelman | Director | San Francisco, CA |
| N/A venBio Global Strategic GP III, Ltd. | Director | San Francisco, CA |
| N/A venBio Global Strategic GP III, L.P. | Director | San Francisco, CA |
Other filings by this issuer (2)
More